Supplemental Filings: House GOP Tries to Ban FDA Pride Flag; Amyloid PET NCD Updates Soon
Executive Summary
As the FDA flies the Progressive Pride Flag in honor of Pride Month, an appropriations bill provision would limit the flags that could be flown at it and other federal agency buildings. Plus news on Medicare's amyloid PET NCD, reimbursement for new end-stage renal disease drugs, opioid disposal and what FDA can't use its user fees for in 2024.
You may also be interested in...
House FY 2024 Approps Bill Nixes US FDA Mifepristone REMS Changes, Cuts Funding
Tobacco rules limiting nicotine and banning menthol in cigarettes also would be defunded in the bill.
FDA Staffing: Retirements Account For More Than One-Third Of FY 2023 Departures
Combination of an aging workforce and departures that were delayed by the pandemic are taking a toll on the agency’s current staffing levels, Chief of Staff Julie Tierney says.
Medicare Registry Plan For Alzheimer’s Drugs Pairs CMS Web Portal With Health System Efforts
Lack of detail on data elements that would be required through the portal has stakeholders wondering if the Centers for Medicare and Medicaid Services has really found a way to make the registry requirement less of a threat to access for Alzheimer’s drugs with traditional FDA approval.